MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | - | ₹1.45 Cr | ₹1.45 Cr | ₹20 Cr | ₹48 Cr |
What is the latest Contingent Liabilities ratio of MARKSANS PHARMA ?
Year | Contingent Liabilities |
---|---|
Mar2024 | - |
Mar2023 | ₹1.45 Cr |
Mar2022 | ₹1.45 Cr |
Mar2021 | ₹20 Cr |
Mar2020 | ₹48 Cr |
How is Contingent Liabilities of MARKSANS PHARMA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | -100.00 | |
Mar2023 | ₹1.45 Cr | 0.00 | |
Mar2022 | ₹1.45 Cr | -92.68 | |
Mar2021 | ₹20 Cr | -58.94 | |
Mar2020 | ₹48 Cr | - |
Compare Contingent Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,996.2 Cr | 5.2% | -18.5% | 64.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,098.0 Cr | 2.3% | -0.8% | 32.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,194.0 Cr | 3.2% | 1.1% | 51.5% | Stock Analytics | |
CIPLA | ₹116,773.0 Cr | 0.3% | -2% | 10% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,646.0 Cr | -1.8% | 2.7% | 12.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,125.0 Cr | 2% | 1.5% | 38% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 5.2% |
-18.5% |
64.8% |
SENSEX | 1% |
-3.9% |
5.1% |
You may also like the below Video Courses